Brief: Anixa Biosciences Reports Encouraging Patient Survival Observations In Ovarian Cancer Car-T Trial
09/02/2026 13:16
Feb 9 (Reuters) - Anixa Biosciences Inc ANIX.O: ANIXA BIOSCIENCES REPORTS ENCOURAGING PATIENT SURVIVAL OBSERVATIONS IN OVARIAN CANCER CAR-T TRIAL; ACHIEVES REGULATORY APPROVAL ENABLING MAJOR DOSE ESCALATION Source text: ID:nPnGrJFYa Further company coverage: ANIX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Anixa Biosciences
See all newsBrief: Anixa Biosciences Announces First Case Of Stable Disease For Three Months In Ovarian Cancer Car-T Clinical Trial
US RESEARCH ROUNDUP- Allstate, Autozone, Vertex Pharmaceuticals
Anixa Biosciences Inc reports results for the quarter ended July 31 - Earnings Summary
Anixa Biosciences Inc expected to post a loss of 9 cents a share - Earnings Preview
Factbox: Moderna-Merck melanoma vaccine leads race for first therapeutic cancer vaccine